Enveric Hires Fish & Richardson To Defend IP Against Petition Claiming Its Patent Contains Claims Relevant To AbbVie's $1.2B Bretisilocin Acquisition

Benzinga
2025.10.15 18:07
portai
I'm PortAI, I can summarize articles.

Enveric Biosciences ( NASDAQ:ENVB ) recently announced that it has hired intellectual property powerhouse Fish and Richardson P.C. to contest a Post-Grant Review ( PGR ) petition filed by rival Gilgamesh Pharmaceuticals against Enveric's issued U.S.

Source: Benzinga The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.